Genetic polimorphism of serotonin transporter and Monoaine Oxidase and response to SSRI antidepressant drugs interminal cancer patients.

SCHILLANI G.; CAPOZZO M.; CONTE A. M.; DEVANNA M.; GIRALDI T.; GRASSI, Luigi

oai:iris.unife.it:11392/524711

Genetic polimorphism of serotonin transporter and Monoaine Oxidase and response to SSRI antidepressant drugs interminal cancer patients.

Authors: SCHILLANI G.
CAPOZZO M.
CONTE A. M.
DEVANNA M.
GIRALDI T.
Luigi GRASSI
Publication date: 1 January 2007
Publisher

Abstract

The Serotonin transporter (SERT) and monoaminooxidase play an important role in monoaminergic transmission and in mood regulation. The 5HTLTTPR polimorphism and the VNTR for MAO were studied among 73 terminal patients with depression. Citaloproam and sertraline were used to treat depression. Efficacy of the 2 drugs was higher in patients with the genetic polimorphism conferring high functional activity of MAO VNTR

Similar works

Full text

Archivio istituzionale della ricerca - Università di Ferrara

oai:iris.unife.it:11392/524711

Last time updated on 12/11/2016

This paper was published in Archivio istituzionale della ricerca - Università di Ferrara.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.